Akimasa Kimura Selected Research

FR 139317

1/2018

Delayed Administration of BQ788, an ETB Antagonist, after Experimental Traumatic Brain Injury Promotes Recovery of Blood-Brain Barrier Function and a Reduction of Cerebral Edema in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akimasa Kimura Research Topics

Disease

2	Brain Edema (Cerebral Edema) 01/2018 - 09/2015
1	Osteolysis 01/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Cold Injury 09/2015

Drug/Important Bio-Agent (IBA)

2	BQ 788IBA 01/2018 - 09/2015
1	MetalsIBA 01/2020
1	Polyethylene (Polythene)IBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 01/2018
1	Endothelin-1 (Endothelin 1)IBA 01/2018
1	FR 139317IBA 01/2018
1	Messenger RNA (mRNA)IBA 09/2015
1	Matrix Metalloproteinases (MMPs)IBA 09/2015
1	IRL 2500IBA 09/2015
1	Endothelins (Endothelin)IBA 09/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015

Therapy/Procedure

1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2020
1	Prostheses and Implants (Prosthesis) 01/2020
1	Intravenous Administration 01/2018